EVENT SITE
WMIF MAIN SITE
Tuesday, June 13, 2023
2:50 PM - 3:30 PM
Watch Panel HerePrecision oncology, defined as molecular profiling of tumors to identify targetable alterations, is rapidly developing and has entered the mainstream of clinical practice. While the focus has been on different mutations, this panel will look at precision medicine from a different lens ranging from unique targets (ie. Menin) to harnessing different effector cells (NK-cells).
Moderators
Elisabeth Battinelli, MD, PhD
Physician, BWH;
Associate Professor, HMS
John Bishai, PhD
Managing Director, Healthcare Investment Banking, BofA Securities
Panelists
Adi Hoess, MD, PhD
CEO, Affimed
Barry Kappel, PhD
Founder, President & CEO, Sapience Therapeutics
Troy Wilson, PhD
President & CEO, Kura Oncology
© 2024 Mass General Brigham Incorporated. All Rights Reserved